Novavax: Health Canada approves Covid 24/25 vaccine
(CercleFinance.com) - Novavax announced that it has applied to Health Canada for approval of its COVID-19 Formula 2024-2025 (NVX-CoV2705) vaccine in children aged 12 and over.
NB pmt -0.3%
Novavax plans to make its vaccine available in Canada for immediate distribution following approval, if public health programs choose to provide this option.
Novavax has also filed applications with the U.S. FDA and the EMA, and is working with other regulatory authorities around the world to obtain clearance or approval for its updated COVID-19 vaccine.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
NB pmt -0.3%
Novavax plans to make its vaccine available in Canada for immediate distribution following approval, if public health programs choose to provide this option.
Novavax has also filed applications with the U.S. FDA and the EMA, and is working with other regulatory authorities around the world to obtain clearance or approval for its updated COVID-19 vaccine.
Copyright (c) 2024 CercleFinance.com. All rights reserved.